TreeWAS – Variant ID: rs1372474

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
F03 Unspecified dementia	0.049	0.951	0.000
F00-F09 Organic, including symptomatic, mental disorders	0.043	0.957	0.000
F05 Delirium, not induced by alcohol and other psychoactive substances	0.039	0.961	0.000
F05.9 Delirium, unspecified	0.038	0.962	0.000
F00 Dementia in Alzheimer's disease	0.038	0.962	0.000
F01 Vascular dementia	0.035	0.965	0.000
F02 Dementia in other diseases classified elsewhere	0.034	0.966	0.000
F00.9 Dementia in Alzheimer's disease, unspecified	0.032	0.968	0.000
F07 Personality and behavioural disorders due to brain disease, damage and dysfunction	0.031	0.969	0.000
F09 Unspecified organic or symptomatic mental disorder	0.031	0.969	0.000
F04 Organic amnesic syndrome, not induced by alcohol and other psychoactive substances	0.031	0.969	0.000
F06 Other mental disorders due to brain damage and dysfunction and to physical disease	0.030	0.970	0.000
F00.0 Dementia in Alzheimer's disease with early onset	0.030	0.970	0.000
F01.9 Vascular dementia, unspecified	0.028	0.971	0.000
F05.1 Delirium superimposed on dementia	0.028	0.971	0.000
F02.3 Dementia in Parkinson's disease	0.028	0.972	0.000
F00.2 Dementia in Alzheimer's disease, atypical or mixed type	0.027	0.973	0.000
F00.1 Dementia in Alzheimer's disease with late onset	0.027	0.973	0.000
F05.0 Delirium not superimposed on dementia, so described	0.027	0.973	0.000
F05.8 Other delirium	0.027	0.973	0.000
F02.0 Dementia in Pick's disease	0.025	0.975	0.000
F01.8 Other vascular dementia	0.025	0.975	0.000
F01.3 Mixed cortical and subcortical vascular dementia	0.025	0.975	0.000
F01.2 Subcortical vascular dementia	0.025	0.975	0.000
F01.1 Multi-infarct dementia	0.025	0.975	0.000
F01.0 Vascular dementia of acute onset	0.025	0.975	0.000
F02.8 Dementia in other specified diseases classified elsewhere	0.025	0.975	0.000
F02.4 Dementia in human immunodeficiency virus [HIV] disease	0.025	0.975	0.000
F02.2 Dementia in Huntington's disease	0.025	0.975	0.000
F02.1 Dementia in Creutzfeldt-Jakob disease	0.025	0.975	0.000
F07.9 Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction	0.022	0.977	0.000
F07.8 Other organic personality and behavioural disorders due to brain disease, damage and dysfunction	0.022	0.977	0.000
F07.2 Postconcussional syndrome	0.022	0.977	0.000
F07.1 Postencephalitic syndrome	0.022	0.977	0.000
F07.0 Organic personality disorder	0.022	0.977	0.000
F06.9 Unspecified mental disorder due to brain damage and dysfunction and to physical disease	0.021	0.978	0.000
F06.8 Other specified mental disorders due to brain damage and dysfunction and to physical disease	0.021	0.978	0.000
F06.6 Organic emotionally labile [asthenic] disorder	0.021	0.978	0.000
F06.5 Organic dissociative disorder	0.021	0.978	0.000
F06.4 Organic anxiety disorder	0.021	0.978	0.000
F06.3 Organic mood [affective] disorders	0.021	0.978	0.000
F06.2 Organic delusional [schizophrenia-like] disorder	0.021	0.978	0.000
F06.1 Organic catatonic disorder	0.021	0.978	0.000
F06.0 Organic hallucinosis	0.021	0.978	0.000
F06.7 Mild cognitive disorder	0.020	0.980	0.000
K83.8 Other specified diseases of biliary tract	0.011	0.989	0.000
K83 Other diseases of biliary tract	0.010	0.990	0.000
B96.5 Pseudomonas (aeruginosa)(mallei)(pseudomallei) as the cause of diseases classified to other chapters	0.000	0.991	0.009
K83.9 Disease of biliary tract, unspecified	0.009	0.991	0.000
K83.1 Obstruction of bile duct	0.009	0.991	0.000
Z95.2 Presence of prosthetic heart valve	0.009	0.991	0.000
K83.0 Cholangitis	0.009	0.991	0.000
K83.3 Fistula of bile duct	0.008	0.992	0.000
K83.5 Biliary cyst	0.007	0.993	0.000
K83.4 Spasm of sphincter of Oddi	0.007	0.993	0.000
K83.2 Perforation of bile duct	0.007	0.993	0.000
Z95.3 Presence of xenogenic heart valve	0.007	0.993	0.000
Z95.0 Presence of cardiac pacemaker	0.007	0.993	0.000
Z95.4 Presence of other heart-valve replacement	0.007	0.993	0.000
Z95 Presence of cardiac and vascular implants and grafts	0.006	0.994	0.000
K35.8 Acute appendicitis, other and unspecified	0.000	0.994	0.006
C92.1 Chronic myeloid leukaemia	0.000	0.994	0.006
C92.0 Acute myeloid leukaemia	0.000	0.994	0.006
K35.3 Acute appendicitis with localized peritonitis	0.000	0.994	0.006
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.006	0.994	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.006	0.994	0.000
C92 Myeloid leukaemia	0.000	0.995	0.005
I86.4 Gastric varices	0.005	0.995	0.000
Y45.0 Opioids and related analgesics	0.005	0.995	0.000
K35 Acute appendicitis	0.000	0.995	0.005
I86.1 Scrotal varices	0.005	0.995	0.000
Y45.2 Propionic acid derivatives	0.005	0.995	0.000
L43.9 Lichen planus, unspecified	0.005	0.995	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.005	0.995	0.000
I86 Varicose veins of other sites	0.005	0.995	0.000
K35.1 Acute appendicitis with peritoneal abscess	0.000	0.995	0.005
Y45.8 Other analgesics and antipyretics	0.004	0.995	0.000
D25.9 Leiomyoma of uterus, unspecified	0.004	0.996	0.000
Y45.5 4-Aminophenol derivatives	0.004	0.996	0.000
Y45.4 Antirheumatics	0.004	0.996	0.000
Z04.8 Examination and observation for other specified reasons	0.000	0.996	0.004
C92.9 Myeloid leukaemia, unspecified	0.000	0.996	0.004
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.000	0.996	0.004
C92.7 Other myeloid leukaemia	0.000	0.996	0.004
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.000	0.996	0.004
C92.5 Acute myelomonocytic leukaemia	0.000	0.996	0.004
C92.4 Acute promyelocytic leukaemia	0.000	0.996	0.004
C92.3 Myeloid sarcoma	0.000	0.996	0.004
C92.2 Subacute myeloid leukaemia	0.000	0.996	0.004
K35.2 Acute appendicitis with generalized peritonitis	0.000	0.996	0.004
R29.8 Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems	0.004	0.996	0.000
C16.9 Stomach, unspecified	0.004	0.996	0.000
Y45.1 Salicylates	0.004	0.996	0.000
B96 Other bacterial agents as the cause of diseases classified to other chapters	0.000	0.996	0.004
C20 Malignant neoplasm of rectum	0.004	0.996	0.000
B96.2 Escherichia coli [E. coli] as the cause of diseases classified to other chapters	0.000	0.996	0.004
C16 Malignant neoplasm of stomach	0.004	0.996	0.000
I12.0 Hypertensive renal disease with renal failure	0.004	0.996	0.000
M48.0 Spinal stenosis	0.004	0.996	0.000
C16.2 Body of stomach	0.004	0.996	0.000
M48.02 Spinal stenosis (Cervical region)	0.004	0.996	0.000
C16.1 Fundus of stomach	0.004	0.996	0.000
I86.3 Vulval varices	0.003	0.996	0.000
I86.2 Pelvic varices	0.003	0.996	0.000
I86.0 Sublingual varices	0.003	0.996	0.000
H02.3 Blepharochalasis	0.000	0.996	0.004
C16.5 Lesser curvature of stomach, unspecified	0.003	0.996	0.000
B96.1 Klebsiella pneumoniae [K. pneumoniae] as the cause of diseases classified to other chapters	0.000	0.997	0.003
M47.12 Other spondylosis with myelopathy (Cervical region)	0.003	0.997	0.000
M48 Other spondylopathies	0.003	0.997	0.000
M48.08 Spinal stenosis (Sacral and sacrococcygeal region)	0.003	0.997	0.000
M48.07 Spinal stenosis (Lumbosacral region)	0.003	0.997	0.000
I82.8 Embolism and thrombosis of other specified veins	0.003	0.997	0.000
I86.8 Varicose veins of other specified sites	0.003	0.997	0.000
M47.1 Other spondylosis with myelopathy	0.003	0.997	0.000
I85.0 Oesophageal varices with bleeding	0.003	0.997	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.003	0.997	0.000
B96.7 Clostridium perfringens [C. perfringens] as the cause of diseases classified to other chapters	0.000	0.997	0.003
B96.6 Bacillus fragilis [B. fragilis] as the cause of diseases classified to other chapters	0.000	0.997	0.003
B96.0 Mycoplasma pneumoniae [M. pneumoniae] as the cause of diseases classified to other chapters	0.000	0.997	0.003
K35.9 Acute appendicitis, unspecified	0.000	0.997	0.003
M47.96 Spondylosis, unspecified (Lumbar region)	0.003	0.997	0.000
B96.3 Haemophilus influenzae [H. influenzae] as the cause of diseases classified to other chapters	0.000	0.997	0.003
C16.8 Overlapping lesion of stomach	0.003	0.997	0.000
C16.6 Greater curvature of stomach, unspecified	0.003	0.997	0.000
C16.4 Pylorus	0.003	0.997	0.000
C16.3 Pyloric antrum	0.003	0.997	0.000
C16.0 Cardia	0.003	0.997	0.000
Y40 Systemic antibiotics	0.003	0.997	0.000
E04.2 Non-toxic multinodular goitre	0.003	0.997	0.000
M48.5 Collapsed vertebra, not elsewhere classified	0.003	0.997	0.000
Y40.8 Other systemic antibiotics	0.003	0.997	0.000
Z95.9 Presence of cardiac and vascular implant and graft, unspecified	0.003	0.997	0.000
I82 Other venous embolism and thrombosis	0.003	0.997	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
M48.54 Collapsed vertebra, not elsewhere classified (Thoracic region)	0.003	0.997	0.000
Y44 Agents primarily affecting blood constituents	0.003	0.997	0.000
M48.09 Spinal stenosis (Site unspecified)	0.003	0.997	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
M48.00 Spinal stenosis (Multiple sites in spine)	0.003	0.997	0.000
C21.1 Anal canal	0.003	0.997	0.000
M48.05 Spinal stenosis (Thoracolumbar region)	0.003	0.997	0.000
M48.04 Spinal stenosis (Thoracic region)	0.003	0.997	0.000
M48.03 Spinal stenosis (Cervicothoracic region)	0.003	0.997	0.000
M48.01 Spinal stenosis (Occipito-atlanto-axial region)	0.003	0.997	0.000
Y57 Other and unspecified drugs and medicaments	0.003	0.997	0.000
M47.16 Other spondylosis with myelopathy (Lumbar region)	0.003	0.997	0.000
S72.30 Fracture of shaft of femur (closed)	0.000	0.997	0.003
I82.2 Embolism and thrombosis of vena cava	0.003	0.997	0.000
M47 Spondylosis	0.003	0.997	0.000
B96.4 Proteus (mirabilis)(morganii) as the cause of diseases classified to other chapters	0.000	0.997	0.003
M47.82 Other spondylosis (Cervical region)	0.003	0.997	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
Y57.9 Drug or medicament, unspecified	0.003	0.997	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.000	0.997	0.003
Y48 Anaesthetics and therapeutic gases	0.003	0.997	0.000
Y44.2 Anticoagulants	0.003	0.997	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.003	0.997	0.000
Y40.5 Aminoglycosides	0.003	0.997	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.003	0.997	0.000
K35.0 Acute appendicitis with generalised peritonitis	0.000	0.997	0.003
Y46 Antiepileptics and anti-Parkinsonism drugs	0.003	0.997	0.000
M48.06 Spinal stenosis (Lumbar region)	0.003	0.997	0.000
I82.3 Embolism and thrombosis of renal vein	0.003	0.997	0.000
Y54.8 Agents affecting uric acid metabolism	0.003	0.997	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.003	0.997	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.000	0.997	0.003
M48.9 Spondylopathy, unspecified	0.003	0.997	0.000
M48.8 Other specified spondylopathies	0.003	0.997	0.000
M48.4 Fatigue fracture of vertebra	0.003	0.997	0.000
M48.3 Traumatic spondylopathy	0.003	0.997	0.000
M48.2 Kissing spine	0.003	0.997	0.000
M48.1 Ankylosing hyperostosis [Forestier]	0.003	0.997	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.000	0.997	0.003
M45-M49 Spondylopathies	0.003	0.997	0.000
N89.8 Other specified noninflammatory disorders of vagina	0.000	0.997	0.003
C21 Malignant neoplasm of anus and anal canal	0.003	0.997	0.000
M47.19 Other spondylosis with myelopathy (Site unspecified)	0.002	0.997	0.000
M47.18 Other spondylosis with myelopathy (Sacral and sacrococcygeal region)	0.002	0.997	0.000
M47.17 Other spondylosis with myelopathy (Lumbosacral region)	0.002	0.997	0.000
M47.15 Other spondylosis with myelopathy (Thoracolumbar region)	0.002	0.997	0.000
M47.14 Other spondylosis with myelopathy (Thoracic region)	0.002	0.997	0.000
M47.13 Other spondylosis with myelopathy (Cervicothoracic region)	0.002	0.997	0.000
M47.11 Other spondylosis with myelopathy (Occipito-atlanto-axial region)	0.002	0.997	0.000
M47.10 Other spondylosis with myelopathy (Multiple sites in spine)	0.002	0.997	0.000
Y48.4 Anaesthetic, unspecified	0.003	0.997	0.000
Y59 Other and unspecified vaccines and biological substances	0.002	0.997	0.000
Y58 Bacterial vaccines	0.002	0.997	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.997	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.002	0.997	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.002	0.997	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.003	0.997	0.000
Y40.3 Macrolides	0.002	0.997	0.000
Y44.5 Thrombolytic drugs	0.002	0.997	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.000	0.997	0.003
C81 Hodgkin's disease	0.000	0.997	0.003
M47.94 Spondylosis, unspecified (Thoracic region)	0.002	0.997	0.000
M47.9 Spondylosis, unspecified	0.003	0.997	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.000	0.997	0.003
I85 Oesophageal varices	0.003	0.997	0.000
C15-C26 Malignant neoplasms of digestive organs	0.003	0.997	0.000
N31.9 Neuromuscular dysfunction of bladder, unspecified	0.000	0.997	0.003
Y40.7 Antifungal antibiotics, systemically used	0.002	0.997	0.000
Y40.6 Rifamycins	0.002	0.997	0.000
Y40.4 Tetracyclines	0.002	0.997	0.000
Y40.2 Chloramphenicol group	0.002	0.997	0.000
Y53.4 Other laxatives	0.002	0.997	0.000
L43 Lichen planus	0.002	0.997	0.000
M48.59 Collapsed vertebra, not elsewhere classified (Site unspecified)	0.002	0.997	0.000
M48.58 Collapsed vertebra, not elsewhere classified (Sacral and sacrococcygeal region)	0.002	0.997	0.000
M48.57 Collapsed vertebra, not elsewhere classified (Lumbosacral region)	0.002	0.997	0.000
M48.55 Collapsed vertebra, not elsewhere classified (Thoracolumbar region)	0.002	0.997	0.000
M48.53 Collapsed vertebra, not elsewhere classified (Cervicothoracic region)	0.002	0.997	0.000
M48.52 Collapsed vertebra, not elsewhere classified (Cervical region)	0.002	0.997	0.000
M48.51 Collapsed vertebra, not elsewhere classified (Occipito-atlanto-axial region)	0.002	0.997	0.000
M48.50 Collapsed vertebra, not elsewhere classified (Multiple sites in spine)	0.002	0.997	0.000
I82.1 Thrombophlebitis migrans	0.002	0.997	0.000
I82.0 Budd-Chiari syndrome	0.002	0.997	0.000
M47.2 Other spondylosis with radiculopathy	0.002	0.997	0.000
O47.9 False labour, unspecified	0.002	0.997	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.998	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
Y51.0 Anticholinesterase agents	0.002	0.998	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.002	0.998	0.000
Y44.7 Plasma substitutes	0.002	0.998	0.000
Y44.6 Natural blood and blood products	0.002	0.998	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.002	0.998	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.002	0.998	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.002	0.998	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.000	0.998	0.002
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
Y53.7 Emetics	0.002	0.998	0.000
Y53.6 Antidiarrhoeal drugs	0.002	0.998	0.000
Y53.5 Digestants	0.002	0.998	0.000
Y53.3 Saline and osmotic laxatives	0.002	0.998	0.000
Y53.2 Stimulant laxatives	0.002	0.998	0.000
Y53.0 Histamine H2-receptor antagonists	0.002	0.998	0.000
C19 Malignant neoplasm of rectosigmoid junction	0.002	0.998	0.000
C54.1 Endometrium	0.000	0.998	0.002
I82.9 Embolism and thrombosis of unspecified vein	0.002	0.998	0.000
Y40.0 Penicillins	0.002	0.998	0.000
C90.2 Plasmacytoma, extramedullary	0.000	0.998	0.002
Y40.1 Cefalosporins and other -lactam antibiotics	0.002	0.998	0.000
Y46.6 Other and unspecified antiepileptics	0.002	0.998	0.000
Y57.7 Vitamins, not elsewhere classified	0.002	0.998	0.000
Y57.6 Other diagnostic agents	0.002	0.998	0.000
Y57.5 X-ray contrast media	0.002	0.998	0.000
Y57.4 Pharmaceutical excipients	0.002	0.998	0.000
Y57.3 Alcohol deterrents	0.002	0.998	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000
Y57.1 Lipotropic drugs	0.002	0.998	0.000
Y57.0 Appetite depressants [anorectics]	0.002	0.998	0.000
M47.0 Anterior spinal and vertebral artery compression syndromes	0.002	0.998	0.000
Y54.5 Other diuretics	0.002	0.998	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.000	0.998	0.002
M49 Spondylopathies in diseases classified elsewhere	0.002	0.998	0.000
M47.97 Spondylosis, unspecified (Lumbosacral region)	0.002	0.998	0.000
K70.3 Alcoholic cirrhosis of liver	0.002	0.998	0.000
Y48.3 Local anaesthetics	0.002	0.998	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.000	0.998	0.002
C94 Other leukaemias of specified cell type	0.000	0.998	0.002
C93 Monocytic leukaemia	0.000	0.998	0.002
C86 Other specified types of T/NK-cell lymphoma	0.000	0.998	0.002
M48.56 Collapsed vertebra, not elsewhere classified (Lumbar region)	0.002	0.998	0.000
K70.4 Alcoholic hepatic failure	0.002	0.998	0.000
S72.3 Fracture of shaft of femur	0.000	0.998	0.002
Y48.5 Therapeutic gases	0.002	0.998	0.000
Y48.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
Y48.1 Parenteral anaesthetics	0.002	0.998	0.000
Y48.0 Inhaled anaesthetics	0.002	0.998	0.000
M47.26 Other spondylosis with radiculopathy (Lumbar region)	0.002	0.998	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.998	0.000
Z95.8 Presence of other cardiac and vascular implants and grafts	0.002	0.998	0.000
C24 Malignant neoplasm of other and unspecified parts of biliary tract	0.002	0.998	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
Y54.9 Mineral salts, not elsewhere classified	0.002	0.998	0.000
Y54.7 Agents affecting calcification	0.002	0.998	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
Y54.4 Loop [high-ceiling] diuretics	0.002	0.998	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.002	0.998	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.002	0.998	0.000
Y54.0 Mineralocorticoids	0.002	0.998	0.000
C95 Leukaemia of unspecified cell type	0.000	0.998	0.002
Y41 Other systemic anti-infectives and antiparasitics	0.002	0.998	0.000
C81.9 Hodgkin's disease, unspecified	0.000	0.998	0.002
T81.0 Haemorrhage and haematoma complicating a procedure, not elsewhere classified	0.002	0.998	0.000
C17 Malignant neoplasm of small intestine	0.002	0.998	0.000
Y46.4 Iminostilbenes	0.002	0.998	0.000
C88 Malignant immunoproliferative diseases	0.000	0.998	0.002
Y46.8 Antispasticity drugs	0.002	0.998	0.000
Y46.7 Anti-Parkinsonism drugs	0.002	0.998	0.000
Y46.5 Valproic acid	0.002	0.998	0.000
Y46.3 Deoxybarbiturates	0.002	0.998	0.000
Y46.2 Hydantoin derivatives	0.002	0.998	0.000
Y46.1 Oxazolidinediones	0.002	0.998	0.000
Y46.0 Succinimides	0.002	0.998	0.000
Y57.8 Other drugs and medicaments	0.002	0.998	0.000
Z03.1 Observation for suspected malignant neoplasm	0.000	0.998	0.002
I80-I89 Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified	0.002	0.998	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.000	0.998	0.002
Y40.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
C17.0 Duodenum	0.002	0.998	0.000
C24.1 Ampulla of Vater	0.002	0.998	0.000
Y56.9 Topical agent, unspecified	0.002	0.998	0.000
Y56.8 Other topical agents	0.002	0.998	0.000
Y56.7 Dental drugs, topically applied	0.002	0.998	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
Y56.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
Y56.3 Emollients, demulcents and protectants	0.002	0.998	0.000
Y56.2 Local astringents and local detergents	0.002	0.998	0.000
Y56.1 Antipruritics	0.002	0.998	0.000
M48.19 Ankylosing hyperostosis [Forestier] (Site unspecified)	0.002	0.998	0.000
M48.18 Ankylosing hyperostosis [Forestier] (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M48.17 Ankylosing hyperostosis [Forestier] (Lumbosacral region)	0.002	0.998	0.000
M48.16 Ankylosing hyperostosis [Forestier] (Lumbar region)	0.002	0.998	0.000
M48.15 Ankylosing hyperostosis [Forestier] (Thoracolumbar region)	0.002	0.998	0.000
M48.14 Ankylosing hyperostosis [Forestier] (Thoracic region)	0.002	0.998	0.000
M48.13 Ankylosing hyperostosis [Forestier] (Cervicothoracic region)	0.002	0.998	0.000
M48.12 Ankylosing hyperostosis [Forestier] (Cervical region)	0.002	0.998	0.000
M48.11 Ankylosing hyperostosis [Forestier] (Occipito-atlanto-axial region)	0.002	0.998	0.000
M48.10 Ankylosing hyperostosis [Forestier] (Multiple sites in spine)	0.002	0.998	0.000
M48.29 Kissing spine (Site unspecified)	0.002	0.998	0.000
M48.28 Kissing spine (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M48.27 Kissing spine (Lumbosacral region)	0.002	0.998	0.000
M48.26 Kissing spine (Lumbar region)	0.002	0.998	0.000
M48.25 Kissing spine (Thoracolumbar region)	0.002	0.998	0.000
M48.24 Kissing spine (Thoracic region)	0.002	0.998	0.000
M48.23 Kissing spine (Cervicothoracic region)	0.002	0.998	0.000
M48.22 Kissing spine (Cervical region)	0.002	0.998	0.000
M48.21 Kissing spine (Occipito-atlanto-axial region)	0.002	0.998	0.000
M48.20 Kissing spine (Multiple sites in spine)	0.002	0.998	0.000
M48.39 Traumatic spondylopathy (Site unspecified)	0.002	0.998	0.000
M48.38 Traumatic spondylopathy (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M48.37 Traumatic spondylopathy (Lumbosacral region)	0.002	0.998	0.000
M48.36 Traumatic spondylopathy (Lumbar region)	0.002	0.998	0.000
M48.35 Traumatic spondylopathy (Thoracolumbar region)	0.002	0.998	0.000
M48.34 Traumatic spondylopathy (Thoracic region)	0.002	0.998	0.000
M48.33 Traumatic spondylopathy (Cervicothoracic region)	0.002	0.998	0.000
M48.32 Traumatic spondylopathy (Cervical region)	0.002	0.998	0.000
M48.31 Traumatic spondylopathy (Occipito-atlanto-axial region)	0.002	0.998	0.000
M48.30 Traumatic spondylopathy (Multiple sites in spine)	0.002	0.998	0.000
M48.49 Fatigue fracture of vertebra (Site unspecified)	0.002	0.998	0.000
M48.48 Fatigue fracture of vertebra (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M48.47 Fatigue fracture of vertebra (Lumbosacral region)	0.002	0.998	0.000
M48.46 Fatigue fracture of vertebra (Lumbar region)	0.002	0.998	0.000
M48.45 Fatigue fracture of vertebra (Thoracolumbar region)	0.002	0.998	0.000
M48.44 Fatigue fracture of vertebra (Thoracic region)	0.002	0.998	0.000
M48.43 Fatigue fracture of vertebra (Cervicothoracic region)	0.002	0.998	0.000
M48.42 Fatigue fracture of vertebra (Cervical region)	0.002	0.998	0.000
M48.41 Fatigue fracture of vertebra (Occipito-atlanto-axial region)	0.002	0.998	0.000
M48.40 Fatigue fracture of vertebra (Multiple sites in spine)	0.002	0.998	0.000
M48.89 Other specified spondylopathies (Site unspecified)	0.002	0.998	0.000
M48.88 Other specified spondylopathies (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M48.87 Other specified spondylopathies (Lumbosacral region)	0.002	0.998	0.000
M48.86 Other specified spondylopathies (Lumbar region)	0.002	0.998	0.000
M48.85 Other specified spondylopathies (Thoracolumbar region)	0.002	0.998	0.000
M48.84 Other specified spondylopathies (Thoracic region)	0.002	0.998	0.000
M48.83 Other specified spondylopathies (Cervicothoracic region)	0.002	0.998	0.000
M48.82 Other specified spondylopathies (Cervical region)	0.002	0.998	0.000
M48.81 Other specified spondylopathies (Occipito-atlanto-axial region)	0.002	0.998	0.000
M48.80 Other specified spondylopathies (Multiple sites in spine)	0.002	0.998	0.000
M48.99 Spondylopathy, unspecified (Site unspecified)	0.002	0.998	0.000
M48.98 Spondylopathy, unspecified (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M48.97 Spondylopathy, unspecified (Lumbosacral region)	0.002	0.998	0.000
M48.96 Spondylopathy, unspecified (Lumbar region)	0.002	0.998	0.000
M48.95 Spondylopathy, unspecified (Thoracolumbar region)	0.002	0.998	0.000
M48.94 Spondylopathy, unspecified (Thoracic region)	0.002	0.998	0.000
M48.93 Spondylopathy, unspecified (Cervicothoracic region)	0.002	0.998	0.000
M48.92 Spondylopathy, unspecified (Cervical region)	0.002	0.998	0.000
M48.91 Spondylopathy, unspecified (Occipito-atlanto-axial region)	0.002	0.998	0.000
M48.90 Spondylopathy, unspecified (Multiple sites in spine)	0.002	0.998	0.000
C82.6 Cutaneous follicle centre lymphoma	0.000	0.998	0.002
C82.5 Diffuse follicle centre lymphoma	0.000	0.998	0.002
C82.4 Follicular lymphoma grade IIIb	0.000	0.998	0.002
C82.3 Follicular lymphoma grade IIIa	0.000	0.998	0.002
C82.2 Large cell, follicular	0.000	0.998	0.002
C82.1 Mixed small cleaved and large cell, follicular	0.000	0.998	0.002
M49.5 Collapsed vertebra in diseases classified elsewhere	0.002	0.998	0.000
C26 Malignant neoplasm of other and ill-defined digestive organs	0.002	0.998	0.000
I81 Portal vein thrombosis	0.002	0.998	0.000
C21.8 Overlapping lesion of rectum, anus and anal canal	0.002	0.998	0.000
C21.2 Cloacogenic zone	0.002	0.998	0.000
C85.1 B-cell lymphoma, unspecified	0.000	0.998	0.002
C81.1 Nodular sclerosis	0.000	0.998	0.002
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.002	0.998	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.002	0.998	0.000
Y47.4 Bromine compounds	0.002	0.998	0.000
Y47.3 Paraldehyde	0.002	0.998	0.000
Y47.2 Chloral derivatives	0.002	0.998	0.000
Y47.1 Benzodiazepines	0.002	0.998	0.000
Y47.0 Barbiturates, not elsewhere classified	0.002	0.998	0.000
Y50.9 Central nervous system stimulant, unspecified	0.002	0.998	0.000
Y50.8 Other central nervous system stimulants	0.002	0.998	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.002	0.998	0.000
Y50.1 Opioid receptor antagonists	0.002	0.998	0.000
Y50.0 Analeptics	0.002	0.998	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
Y55.5 Anticommon cold drugs	0.002	0.998	0.000
Y55.4 Expectorants	0.002	0.998	0.000
Y55.3 Antitussives	0.002	0.998	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
Y55.0 Oxytocic drugs	0.002	0.998	0.000
Y58.9 Other and unspecified bacterial vaccines	0.002	0.998	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.002	0.998	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.002	0.998	0.000
Y58.5 Diphtheria vaccine	0.002	0.998	0.000
Y58.4 Tetanus vaccine	0.002	0.998	0.000
Y58.3 Plague vaccine	0.002	0.998	0.000
Y58.2 Cholera vaccine	0.002	0.998	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.002	0.998	0.000
Y58.0 BCG vaccine	0.002	0.998	0.000
Y59.9 Vaccine or biological substance, unspecified	0.002	0.998	0.000
Y59.8 Other specified vaccines and biological substances	0.002	0.998	0.000
Y59.3 Immunoglobulin	0.002	0.998	0.000
Y59.2 Protozoal vaccines	0.002	0.998	0.000
Y59.1 Rickettsial vaccines	0.002	0.998	0.000
Y59.0 Viral vaccines	0.002	0.998	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.000	0.998	0.002
C85.0 Lymphosarcoma	0.000	0.998	0.002
K70.0 Alcoholic fatty liver	0.002	0.998	0.000
M47.98 Spondylosis, unspecified (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M47.95 Spondylosis, unspecified (Thoracolumbar region)	0.002	0.998	0.000
M47.93 Spondylosis, unspecified (Cervicothoracic region)	0.002	0.998	0.000
M47.91 Spondylosis, unspecified (Occipito-atlanto-axial region)	0.002	0.998	0.000
C81.7 Other Hodgkin's disease	0.000	0.998	0.002
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.000	0.998	0.002
C81.3 Lymphocytic depletion	0.000	0.998	0.002
C81.2 Mixed cellularity	0.000	0.998	0.002
C81.0 Lymphocytic predominance	0.000	0.998	0.002
C90.3 Solitary plasmacytoma	0.000	0.998	0.002
C90.1 Plasma cell leukaemia	0.000	0.998	0.002
I88 Nonspecific lymphadenitis	0.002	0.998	0.000
M46 Other inflammatory spondylopathies	0.002	0.998	0.000
M45 Ankylosing spondylitis	0.002	0.998	0.000
M49.54 Collapsed vertebra in diseases classified elsewhere (Thoracic region)	0.002	0.998	0.000
L43.3 Subacute (active) lichen planus	0.002	0.998	0.000
L43.2 Lichenoid drug reaction	0.002	0.998	0.000
L43.1 Bullous lichen planus	0.002	0.998	0.000
L43.0 Hypertrophic lichen planus	0.002	0.998	0.000
M47.29 Other spondylosis with radiculopathy (Site unspecified)	0.002	0.998	0.000
M47.28 Other spondylosis with radiculopathy (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M47.25 Other spondylosis with radiculopathy (Thoracolumbar region)	0.002	0.998	0.000
M47.24 Other spondylosis with radiculopathy (Thoracic region)	0.002	0.998	0.000
M47.23 Other spondylosis with radiculopathy (Cervicothoracic region)	0.002	0.998	0.000
M47.21 Other spondylosis with radiculopathy (Occipito-atlanto-axial region)	0.002	0.998	0.000
M47.20 Other spondylosis with radiculopathy (Multiple sites in spine)	0.002	0.998	0.000
S70.9 Superficial injury of hip and thigh, unspecified	0.000	0.998	0.002
M47.22 Other spondylosis with radiculopathy (Cervical region)	0.002	0.998	0.000
I88.9 Nonspecific lymphadenitis, unspecified	0.002	0.998	0.000
L43.8 Other lichen planus	0.002	0.998	0.000
M47.8 Other spondylosis	0.002	0.998	0.000
M47.09 Anterior spinal and vertebral artery compression syndromes (Site unspecified)	0.002	0.998	0.000
M47.08 Anterior spinal and vertebral artery compression syndromes (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M47.07 Anterior spinal and vertebral artery compression syndromes (Lumbosacral region)	0.002	0.998	0.000
M47.06 Anterior spinal and vertebral artery compression syndromes (Lumbar region)	0.002	0.998	0.000
M47.05 Anterior spinal and vertebral artery compression syndromes (Thoracolumbar region)	0.002	0.998	0.000
M47.04 Anterior spinal and vertebral artery compression syndromes (Thoracic region)	0.002	0.998	0.000
M47.03 Anterior spinal and vertebral artery compression syndromes (Cervicothoracic region)	0.002	0.998	0.000
M47.02 Anterior spinal and vertebral artery compression syndromes (Cervical region)	0.002	0.998	0.000
M47.01 Anterior spinal and vertebral artery compression syndromes (Occipito-atlanto-axial region)	0.002	0.998	0.000
M47.00 Anterior spinal and vertebral artery compression syndromes (Multiple sites in spine)	0.002	0.998	0.000
C82.0 Small cleaved cell, follicular	0.000	0.998	0.002
C84.4 Peripheral T-cell lymphoma	0.000	0.998	0.002
C90.0 Multiple myeloma	0.000	0.998	0.002
I83.2 Varicose veins of lower extremities with both ulcer and inflammation	0.002	0.998	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.000	0.998	0.002
I12 Hypertensive renal disease	0.002	0.998	0.000
K70 Alcoholic liver disease	0.002	0.998	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.000	0.998	0.002
C84.8 Cutaneous T-cell lymphoma, unspecified	0.000	0.998	0.002
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.000	0.998	0.002
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.000	0.998	0.002
C84.5 Other and unspecified T-cell lymphomas	0.000	0.998	0.002
C84.3 Lymphoepithelioid lymphoma	0.000	0.998	0.002
C84.2 T-zone lymphoma	0.000	0.998	0.002
C84.1 Sezary's diease	0.000	0.998	0.002
C84.0 Mycosis fungoides	0.000	0.998	0.002
M49.8 Spondylopathy in other diseases classified elsewhere	0.002	0.998	0.000
M49.4 Neuropathic spondylopathy	0.002	0.998	0.000
M49.3 Spondylopathy in other infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
M49.2 Enterobacterial spondylitis	0.002	0.998	0.000
M49.1 Brucella spondylitis	0.002	0.998	0.000
M49.0 Tuberculosis of spine	0.002	0.998	0.000
S72.31 Fracture of shaft of femur (open)	0.000	0.998	0.002
C24.9 Biliary tract, unspecified	0.002	0.998	0.000
C24.8 Overlapping lesion of biliary tract	0.002	0.998	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.000	0.998	0.002
C86.5 Angioimmunoblastic T-cell lymphoma	0.000	0.998	0.002
C86.4 Blastic NK-cell lymphoma	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations